Home - Products - Tyrosine Kinase - c-RET - Vepafestinib

Vepafestinib

CAS No. 2129515-96-2

Vepafestinib( —— )

Catalog No. M37628 CAS No. 2129515-96-2

Vepafestinib is a RET inhibitor with potential antineoplastic activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	201	In Stock
5MG	312	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Vepafestinib
Note

Research use only, not for human use.
Brief Description

Vepafestinib is a RET inhibitor with potential antineoplastic activity.
Description

Vepafestinib (TAS0953/HM06; compound 6) is a RET inhibitor (extracted from patent WO2019039439). Vepafestinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Tyrosine Kinase
Target

c-RET
Recptor

c-RET
Research Area

——
Indication

——

Chemical Information

CAS Number

2129515-96-2
Formula Weight

474.55
Molecular Formula

C26H30N6O3
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 50 mg/mL (105.36 mM; Ultrasonic )
SMILES

COCc1ccc(NC(=O)c2c(C#CCN3CCOCC3)n(c3ncnc(N)c23)C2(C)CC2)cc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Hayashi, Kohei, et al. FUSION PROTEIN OF DCTN1 PROTEIN WITH RET PROTEIN. WO2019039439.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

BBT594

BBT594(NVP-BBT594) is a potent inhibitor of receptor tyrosine kinase RETTreatment of cancer.
RET-IN-3

RET-IN-3 is a RETV804M kinase inhibitor with potential anticancer activity for the study of non-small cell lung cancer.
DUN73423

DUN73423 (RET-IN-21) is a potent tyrosine kinase (RET) inhibitor with antitumour activity for the study of cancer.

Sign In Join Free